(PharmaNewsWire.Com, July 24, 2017 ) Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings. Manufacturers are increasingly shifting toward shortened analyzer product cycles with value-added features such as portability of instruments to stay ahead in the market.
Publisher's analysts forecast the global women's health diagnostics market to grow at a CAGR of 6.58% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global women's health diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from biomarkers is considered.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Women's Health Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
